0001493152-19-015454.txt : 20191015 0001493152-19-015454.hdr.sgml : 20191015 20191015065618 ACCESSION NUMBER: 0001493152-19-015454 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190802 FILED AS OF DATE: 20191015 DATE AS OF CHANGE: 20191015 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: 10X Fund, L.P. CENTRAL INDEX KEY: 0001453356 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31791 FILM NUMBER: 191149068 BUSINESS ADDRESS: STREET 1: 1099 FOREST LAKE TERRACE CITY: NICEVILLE STATE: FL ZIP: 32578 BUSINESS PHONE: 208-263-6695 MAIL ADDRESS: STREET 1: 1099 FOREST LAKE TERRACE CITY: NICEVILLE STATE: FL ZIP: 32578 FORMER NAME: FORMER CONFORMED NAME: 10X FUND LP DATE OF NAME CHANGE: 20090107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: 10X Capital Management, LLC CENTRAL INDEX KEY: 0001457247 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31791 FILM NUMBER: 191149069 BUSINESS ADDRESS: STREET 1: 1099 FOREST LAKE TERRACE CITY: NICEVILLE STATE: FL ZIP: 32578 BUSINESS PHONE: 850-502-7659 MAIL ADDRESS: STREET 1: 1099 FOREST LAKE TERRACE CITY: NICEVILLE STATE: FL ZIP: 32578 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CZIRR JAMES C CENTRAL INDEX KEY: 0001260641 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31791 FILM NUMBER: 191149070 MAIL ADDRESS: STREET 1: 4908 SOUTH ASHTON COURT CITY: SPOKANE STATE: WA ZIP: 99223 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GALECTIN THERAPEUTICS INC CENTRAL INDEX KEY: 0001133416 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043562325 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD STREET 2: SUITE 240 CITY: NORCROSS STATE: GA ZIP: 30071 BUSINESS PHONE: 678-620-3186 MAIL ADDRESS: STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD STREET 2: SUITE 240 CITY: NORCROSS STATE: GA ZIP: 30071 FORMER COMPANY: FORMER CONFORMED NAME: PRO PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010612 4 1 ownership.xml X0306 4 2019-08-02 0 0001133416 GALECTIN THERAPEUTICS INC GALT 0001453356 10X Fund, L.P. 545 DUTCH VALLEY ROAD, N.E., SUITE A ATLANTA, GA 30324 0 0 1 0 0001457247 10X Capital Management, LLC 545 DUTCH VALLEY ROAD, N.E., SUITE A ATLANTA, GA 30324 0 0 0 1 General partner 0001260641 CZIRR JAMES C 545 DUTCH VALLEY ROAD, N.E., SUITE A ATLANTA, GA 30324 0 0 0 1 Managing Member of GP Common Stock 2019-08-02 4 J 0 38690 D 6402790 D Common Stock 2019-10-10 4 S 0 17000 3.725 D 6385790 D 10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Shares sold pursuant to 10X Fund, LP's Quarterly Liquidity Program. Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security pursuant to applicable law. /s/ James C. Czirr, as Managing Member of the General Partner for 10X Fund, LP 2019-10-15 /s/ James C. Czirr, as Managing Member of 10X Capital Management, LLC 2019-10-15 /s/ James C. Czirr, Individually 2019-10-15